Toggle navigation
Home
Search
Services
Blog
Contact
About
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M.
Ceregene, Inc., San Diego, CA, United States
Search 3 grants from Katherine Bishop
Search grants from Ceregene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Systems Neuroscience Imaging Resource
OT-based Cognitive Rehabilitation of Cocaine Abusers
Afferent signaling in voiding reflex maturation
Regulation of Dynein-Driven Flagellar Motility
Nitric Oxide Synthase and Early Response Genes After Endotoxin Instillation
Recently added grants:
Osmotic Properties of Healthy and Degenerated Cell Pericellular Matrix
Development of a Mind Body Program to Reduce Knee Pain in Obese Osteoarthritis Patients with Comorbid Depression
Novel methods of acupuncture delivery in the treatment of drug-abuse disorders
Therapeutic approaches to ER mutant breast cancer
Advanced breast tomosynthesis reconstruction for improved cancer diagnosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
3R44NS044652-02S1
Application #
6844444
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Murphy, Diane
Project Start
2002-09-30
Project End
2005-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$199,878
Indirect Cost
Institution
Name
Ceregene, Inc.
Department
Type
DUNS #
019139414
City
San Diego
State
CA
Country
United States
Zip Code
92121
Related projects
NIH 2004
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bartus, Raymond / Ceregene, Inc.
$157,635
NIH 2004
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M. / Ceregene, Inc.
$199,878
NIH 2003
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M. / Ceregene, Inc.
$701,862
Publications
Bishop, Kathie M; Hofer, Eva K; Mehta, Arpesh et al.
(2008)
Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.
Exp Neurol 211:574-84
Comments
Be the first to comment on Katherine Bishop's grant